United States· US:84897-052_135af82c-ec68-4d72-a882-22e662c2f38a
Dimethyl Sulfoxide
A dimethyl sulfoxide product containing dimethyl sulfoxide, registered in United States by Renova Pharmaceuticals LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dimethyl sulfoxide is registered in 4 of 19 countries.
Countries holding a registration under ATC G04BX13 (dimethyl sulfoxide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Dimethyl sulfoxide · ATC G04BX13
4 / 19 countries
- Canada
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DIMETHYL SULFOXIDE
- Manufacturer
- Renova Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- G04BX13
- ATC class
- Dimethyl sulfoxide
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1184897-052-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dimethyl sulfoxide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDimethyl sulfoxide 50% creamSpecial Order
- CanadaRIMSO-50MYLAN PHARMACEUTICALS ULC
- Japanジメチルスルホキシド杏林製薬
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Latvia · Osteogēls
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/80d296b4-39c6-4590-98ed-d4f83ba67a70 GET /v1/drugs/80d296b4-39c6-4590-98ed-d4f83ba67a70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVESICAL",
"source": "ndc",
"strength": ".54",
"substance": "DIMETHYL SULFOXIDE",
"productndc": "84897-052",
"dosage_form": "IRRIGANT",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "ANDA220173",
"marketing_category": "ANDA"
}See everything about dimethyl sulfoxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.